Abstract |
Activation of nuclear transcription factor kappaB ( NF-kappaB) by chemotherapeutic agents was found to protect cells from apoptosis. In light of its central role in regulating the cellular resistance to apoptotic agents, inhibition of NF-kappaB-mediated gene transcription may sensitize tumor cells to chemotherapeutic agents and enhance their efficacy. We describe herein a noncytotoxic imidazoline scaffold that sensitizes leukemia T cells to the chemotherapeutic agent camptothecin. No significant induction of apoptosis was found when cells were treated with the imidazoline; however, pretreatment of cells with this agent resulted in a drastic enhancement in efficacy of camptothecin (approximately 75-fold). Elucidation of the potential cellular mechanism revealed that the imidazoline prevents nuclear translocation of NF-kappaB. These findings indicate that inhibition of NF-kappaB by this imidazoline may present improved strategies in the chemotherapeutic treatment of cancer.
|
Authors | Vasudha Sharma, Theresa A Lansdell, Satyamaheshwar Peddibhotla, Jetze J Tepe |
Journal | Chemistry & biology
(Chem Biol)
Vol. 11
Issue 12
Pg. 1689-99
(Dec 2004)
ISSN: 1074-5521 [Print] United States |
PMID | 15610853
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- I-kappa B Proteins
- Imidazolines
- NF-kappa B
- NFKBIA protein, human
- NF-KappaB Inhibitor alpha
- Luciferases
- Camptothecin
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Apoptosis
(drug effects)
- Camptothecin
(pharmacology)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Humans
- I-kappa B Proteins
(drug effects, metabolism)
- Imidazolines
(chemical synthesis, pharmacology)
- Leukemia, T-Cell
(drug therapy, metabolism)
- Luciferases
(analysis)
- Models, Biological
- Molecular Conformation
- NF-KappaB Inhibitor alpha
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Phosphorylation
- Sensitivity and Specificity
|